| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Bosentan | FAERS: 4 | OFFSIDES US FAERS | |
| 2 | Sunitinib | FAERS: 3 | OFFSIDES US FAERS | |
| 3 | Canagliflozin | FAERS: 2 | US FAERS | |
| 4 | Capecitabine | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | PCI 32765 | FAERS: 2 | US FAERS | |
| 6 | Rosiglitazone | FAERS: 2 | OFFSIDES US FAERS | |
| 7 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 1 | US FAERS | |
| 8 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 1 | US FAERS | |
| 9 | Ceftriaxone | FAERS: 1 | US FAERS | |
| 10 | Imiquimod | FAERS: 1 | US FAERS | |
| 11 | Isotretinoin | FAERS: 1 | US FAERS | |
| 12 | Omeprazole | FAERS: 1 | US FAERS | |
| 13 | Ribavirin | FAERS: 1 | US FAERS | |
| 14 | empagliflozin | FAERS: 1 | US FAERS | |
| 15 | ledipasvir, sofosbuvir drug combination | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 16 | pazopanib | FAERS: 1 | US FAERS | |
| 17 | regorafenib | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Bupivacaine | OFFSIDES | ||
| 19 | Ciprofloxacin | OFFSIDES | ||
| 20 | Clonidine | OFFSIDES | ||
| 21 | Fluocinonide | OFFSIDES | ||
| 22 | Gabapentin | OFFSIDES | ||
| 23 | Octreotide | OFFSIDES | ||
| 24 | Pamidronate | OFFSIDES | ||
| 25 | Ropivacaine | OFFSIDES | ||
| 26 | Sildenafil Citrate | OFFSIDES | ||
| 27 | chlorhexidine gluconate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.